Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-03-02Clinical Trial Update: Breast Cancer Associated Antibodies
An update on a clinical trial investigating antibodies associated with breast cancer; the current study status is unknown.
-
CLINICAL_TRIALS trial_result · 2007-02-28Clinical Trial Update: DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer [Phase 3]
Phase 3 trial of DPPE in combination with Epirubicin and Cyclophosphamide for breast cancer with metastases has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-02-21Clinical Trial Update: Ultrasound and Chemotherapy of Breast Cancer: Relationship Between Early Vascular Changes of the Tumor and Late Tumoral Response [NA]
A completed clinical trial evaluated the relationship between early tumor vascular changes seen on ultrasound during chemotherapy for breast…
-
CLINICAL_TRIALS trial_result · 2007-02-21Clinical Trial Update: Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast Cancer [NA]
This study evaluated neoadjuvant hormonal therapy in postmenopausal women with operable breast cancer. The trial status is completed.
-
CLINICAL_TRIALS research · 2007-02-13Clinical Trial Update: Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer [Phase 2]
Phase 2 trial comparing sequential docetaxel followed by capecitabine to concomitant docetaxel/capecitabine in early-stage breast cancer; cu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2007-02-12Clinical Trial Update: Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer. [NA]
Terminated clinical trial comparing Essiac (ESIAK) to placebo to improve quality of life in women transitioning with breast or ovarian cance…
-
CLINICAL_TRIALS trial_result · 2007-02-09Clinical Trial Update: SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer [Phase 2]
A Phase 2 trial evaluating Faslodex (fulvestrant) after aromatase inhibitor failure in advanced breast cancer has completed.
-
FDA approval · 2007-02-02FDA Approved: TAMOXIFEN CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for tamoxifen citrate (generic) from Mylan Pharmaceuticals, supporting continued approval for th…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine plus paclitaxel and gemcitabine plus docetaxel in metastatic breast cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer [Phase 2]
This clinical trial update reports results from a Phase 2 study of biweekly pemetrexed in combination with gemcitabine for metastatic breast…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer [Phase 2]
This update notes the completion of a Phase 2 trial of pemetrexed plus carboplatin in locally advanced or metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Raloxifene Use for The Heart [Phase 3]
A Phase 3 trial evaluating raloxifene for heart-related outcomes in cardiovascular disease and breast cancer contexts has completed.
-
FDA approval · 2007-01-25FDA Approved: TAMOXIFEN CITRATE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Tamoxifen Citrate submitted by Actavis Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2007-01-19Clinical Trial Update: Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer [Phase 2]
Phase 2 trial update evaluating letrozole for breast cancer prevention in postmenopausal women at increased risk.
-
CLINICAL_TRIALS trial_result · 2007-01-09Clinical Trial Update: Use of Hair to Diagnose Breast Cancer [Phase 1, Phase 2]
This clinical trial update describes Phase 1 and Phase 2 studies investigating whether analysis of hair can diagnose breast cancer.
-
CLINICAL_TRIALS research · 2007-01-09Clinical Trial Update: Use of Hair to Diagnose the Presence of Breast Cancer [Phase 1, Phase 2]
An early-phase study evaluating whether hair analysis can detect the presence of breast cancer, conducted in Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2007-01-09Clinical Trial Update: Study of GPX-100 in the Treatment of Metastatic Breast Cancer [Phase 2]
A Phase 2 study of GPX-100 for metastatic breast cancer has been terminated.
-
CLINICAL_TRIALS research · 2007-01-08Clinical Trial Update: Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas
This clinical trial update describes a proteomic analysis of the HLA complex across multiple solid cancers, including breast, ovarian, color…
-
CLINICAL_TRIALS trial_result · 2006-12-05Clinical Trial Update: Expanding Rural Access: Distance Delivery of Support [Phase 2]
Phase 2 clinical trial update on expanding rural access through distance-delivery support; the study has completed.
-
CLINICAL_TRIALS research · 2006-12-05Clinical Trial Update: Using Test of SCM for Detection Breast Cancer
This document provides a clinical trial update on using a Test of SCM for detection of breast cancer, with the trial status listed as UNKNOW…
-
CLINICAL_TRIALS trial_result · 2006-12-04Clinical Trial Update: Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients [Phase 2]
Phase 2 clinical trial assessing the safety and efficacy of an intravenous loading dose of ibandronate in patients with breast cancer.
-
FDA approval · 2006-12-01FDA Approved: TAMOXIFEN CITRATE — Supplemental Application (Mayne Pharma Commercial LLC)
The FDA approved a supplemental application for tamoxifen citrate from Mayne Pharma Commercial LLC.
-
EMA safety_alert · 2006-11-22Defect in Herceptin vials identified but supply for patients is maintained
A defect was identified in Herceptin vials, but supply for patients is maintained.
-
CLINICAL_TRIALS trial_result · 2006-11-14Clinical Trial Update: Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer [Phase 2]
A Phase 2 study evaluating ZARNESTRA in combination with Tamoxifen for advanced or metastatic breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2006-11-03Clinical Trial Update: Hydralazine and Valproate Added to Chemotherapy for Breast Cancer [Phase 2]
A Phase 2 trial investigating adding hydralazine and valproate to chemotherapy for locally advanced breast cancer has been terminated.